KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Oct 17, 2019 $48.89 $50.35 $48.83 $49.56 518 689
Oct 16, 2019 $47.96 $48.87 $47.52 $48.68 421 805
Oct 15, 2019 $46.85 $48.64 $46.70 $48.07 573 597
Oct 14, 2019 $46.80 $48.10 $45.83 $46.49 492 055
Oct 11, 2019 $46.13 $48.25 $45.51 $46.53 1 006 228
Oct 10, 2019 $47.09 $47.61 $45.60 $45.97 799 050
Oct 09, 2019 $48.10 $49.41 $47.06 $47.15 1 060 816
Oct 08, 2019 $45.05 $47.64 $44.17 $46.46 1 294 360
Oct 07, 2019 $47.93 $48.45 $45.50 $45.70 994 936
Oct 04, 2019 $49.09 $49.38 $47.70 $48.06 452 406
Oct 03, 2019 $47.16 $49.16 $46.22 $48.98 557 963
Oct 02, 2019 $46.58 $47.81 $45.64 $47.40 688 619
Oct 01, 2019 $48.70 $49.68 $46.59 $46.99 667 565
Sep 30, 2019 $49.63 $49.65 $47.63 $48.52 596 801
Sep 27, 2019 $51.56 $52.15 $49.05 $49.29 780 993
Sep 26, 2019 $54.12 $54.68 $50.25 $51.34 839 502
Sep 25, 2019 $54.67 $55.41 $53.54 $54.27 536 069
Sep 24, 2019 $56.19 $56.24 $53.86 $54.45 1 168 755
Sep 23, 2019 $54.70 $56.59 $54.15 $55.95 893 911
Sep 20, 2019 $54.30 $54.86 $53.58 $54.68 1 282 029
Sep 19, 2019 $53.11 $54.56 $52.68 $53.82 528 776
Sep 18, 2019 $52.62 $53.74 $51.72 $52.85 620 622
Sep 17, 2019 $52.98 $53.36 $51.42 $53.03 608 965
Sep 16, 2019 $53.57 $54.80 $52.81 $53.14 519 713
Sep 13, 2019 $54.35 $55.50 $53.37 $54.04 739 179
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT